Skip to content
Screener

Illumina ILMN Q1 2025 earnings

Reported April 30, 2026 · After market close

Next report

Oct 29, 2026 (in 2 months)
Revenue estimate$1.2B
EPS estimate$1.38

Financials

Q1 2025

Income statement

See full
Revenue$1.0B-3.3%
Gross profit$683.0M+2.4%
Operating income$164.0M+248%
Net income$131.0M+204%
EPS (diluted)$0.82+204%

Balance sheet

See full
Cash & equivalents$1.1B+0.5%
Total debt$2.1B-7.4%
Total equity$2.4B-58.7%
Total assets$6.2B-38.4%

Cash flow

See full
Operating cash flow$240.0M+212%
CapEx$32.0M-11.1%
Free cash flow$208.0M+407%

Valuation & ratios

Valuation

as of 04/02/25
See full
Market cap$12.57B-42.4%
Enterprise value$13.56B-41.0%
P/S2.9×-2.0×

Profitability

See full
Gross margin66.3%+5.0pp
Net margin-22.3%-4.1pp
FCF margin20.2%+12.1pp

Returns & leverage

See full
Return on equity-23.8%+4.2pp
Debt / equity0.9×+0.5×
Current ratio1.9×+0.1×

Segments

By product

See full
Consumables$768.0M+0.8%
Service$161.0M-19.5%
Instruments$112.0M-1.8%

By segment

See full
Sequencing$947.0M-3.3%
Microarray$94.0M-3.1%

FAQ

When did Illumina report Q1 2025 earnings?
Illumina (ILMN) reported Q1 2025 earnings on April 30, 2026 after market close.
What were Illumina's Q1 2025 revenue and EPS?
Illumina reported revenue of $1.0B and diluted eps of $0.82 for Q1 2025.
How did Illumina's Q1 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 3.3% from $1.1B a year earlier.
Where can I find Illumina's Q1 2025 SEC filings?
You can read the 8-K earnings release (0001110803-26-000087) and the 10-Q periodic report (0001110803-25-000046) directly on SEC EDGAR. The filing index links above go to sec.gov.